fda promulg regul ensur among thing drug product held pend use intend consum manner ensur safeti part 210 211 21 cfr part 210 211 term held includ manufactur ship time also time point purchas consum use thu manufactur respons manner product held pend actual consum use respons packag use adequ prevent unintend ingest iron children regul replet exampl fda author regul manufactur beyond point ship product manufactur site exampl 211 94 b requir contain closur system provid adequ protect forese extern factor storag use caus deterior contamin drug product emphasi ad regul requir manufactur protect deterior contamin occur storag drug product throughout chain distribut point use consum section 501 2 b act manufactur also respons prevent intent misus drug product 1982 respons seri capsul tamper fda promulg regul 211 132 requir tamper resist packag counter otc human drug product except dermatolog dentifric insulin 47 fr 50442 agenc action assur greater packag integr product secur beyond point manufactur fda author requir tamper resist packag found primarili section 501 2 b act significantli health risk prompt tamper resist packag regul attribut directli manufactur pack practic contraven current good manufactur practic regul effect time rather despit complianc exist regul drug product qualiti compromis previous unforese unintend intervent person consum tamper resist packag mean obviat newli appar danger tamper resist packag technolog avail current good manufactur practic mandat use similarli 1989 recogn persist vulner hard capsul dosag form fda amend tamper resist regul requir otc product market two piec hard gelatin capsul packag use least two tamper resist featur 54 fr 5227 februari 2 1989 likewis 1994 agenc propos amend tamper resist regul requir packag otc human drug product market two piec hard gelatin capsul seal 59 fr 2542 januari 18 1994 propos amend part agenc continu review potenti public health threat pose product tamper propos address specif vulner otc market improv consum protect 59 fr 2543 preambl propos rule fda recogn although packag use time latest poison incid met fda requir effect time packag design reveal visibl evid tamper propos rule would chang tamper resist tamper evid underscor fact current packag technolog invulner tamper would requir packag erect barrier tamper also alert consum sign tamper addit septemb 1993 fda publish regul requir imprint solid oral dosag form drug product human use see 58 fr 47948 septemb 13 1993 regul requir everi product imprint code allow identif drug product manufactur distributor regul ensur among thing consum health care profession inform avail event emerg imprint rule like propos rule iron contain product respond concern relat consum use drug product rather concern focus integr composit product propos rule therefor like pertain tamper evid packag drug imprint intend enhanc safeti drug product specif iron contain drug product recent statist data avail fda demonstr current manner hold iron contain drug product use intend consum fail ensur drug product safe larg number children ingest product suffer seriou injuri death exist technolog permit addit safeguard child resist blister pack use hold iron contain drug product given known danger abil minim elimin danger use exist technolog fda tent conclud current good manufactur practic dictat unit dose packag use